- ISIN
- US47973J1025
- CUSIP
- 47973J102
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- IPO Date
- Nov 11, 2014
Highlights
- Market Cap
- $118.18M
- Enterprise Value
- $99.82M
- EPS (TTM)
- $0.22
- PE Ratio
- 37.68
- PEG Ratio
- 0.31
- Total Revenue (TTM)
- $56.64M
- Gross Profit (TTM)
- $44.47M
- EBITDA (TTM)
- $3.13M
- Year Range
- $7.50 - $11.26
- Target Price
- $20.00
- ROA (TTM)
- 5.59%
- ROE (TTM)
- 20.94%
- Avg. Volume (1M)
- 78K
- Avg. Volume Value (1M)
- $693.85K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
JYNT Performance Chart
The Joint Corp. (JYNT) is down 4.9% since the beginning of the year. At $8 per share, JYNT is trading 26.3% below its 52-week high of $11. Investors who bought $1,000 worth of JYNT shares 5 years ago would now be looking at an investment worth $105.
Loading charts...
Compare this symbol against anything
Returns By Period
The Joint Corp. (JYNT) has returned -4.93% so far this year and -24.15% over the past 12 months. Looking at the last ten years, JYNT has achieved an annualized return of 14.29%, outperforming the S&P 500 Index benchmark, which averaged 13.26% per year.
The Joint Corp.
- 1D
- -0.96%
- 1M
- -7.58%
- 6M
- -15.24%
- YTD
- -4.93%
- 1Y
- -24.15%
- 3Y*
- -14.75%
- 5Y*
- -36.29%
- 10Y*
- 14.29%
- ALL TIME*
- 1.94%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
JYNT Monthly Returns History
Based on dividend-adjusted daily data since Nov 11, 2014, JYNT's average daily return is +0.07%, while the average monthly return is +1.32%. At this rate, an investment would double in approximately 4.4 years.
Historically, 53% of months were positive and 47% were negative. The best month was Mar 2019 with a return of +43.7%, while the worst month was May 2022 at -45.4%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 10 months.
On a daily basis, JYNT closed higher 48% of trading days. The best single day was Mar 8, 2024 with a return of +30.0%, while the worst single day was May 6, 2022 at -37.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 12.16% | -10.02% | 0.57% | 0.23% | 0.34% | -1.35% | -5.58% | -4.93% | |||||
| 2025 | 3.95% | 2.71% | 10.04% | -19.86% | 6.89% | 7.85% | -4.33% | -2.72% | -11.17% | -17.30% | 6.72% | 3.56% | -17.97% |
| 2024 | 1.56% | 1.02% | 32.45% | -8.58% | 25.71% | -6.33% | 2.56% | -21.57% | 1.15% | -3.41% | 5.34% | -8.68% | 10.61% |
| 2023 | 29.97% | -13.59% | 7.20% | -6.18% | -10.20% | -4.80% | 0.00% | -31.19% | -3.23% | -13.13% | 12.55% | 9.33% | -31.26% |
| 2022 | -17.73% | -24.13% | -13.68% | -13.76% | -45.35% | -8.21% | 11.69% | 6.67% | -13.87% | 5.16% | -9.75% | -6.24% | -78.72% |
| 2021 | 23.88% | 22.38% | 21.50% | 14.70% | 28.12% | 18.06% | -5.87% | 29.35% | -4.06% | -10.75% | -8.64% | -17.81% | 150.15% |
Benchmark Metrics
The Joint Corp. has an annualized alpha of 4.72%, beta of 1.09, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since November 11, 2014.
- This stock participated in 139.97% of S&P 500 Index downside but only 96.62% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 4.72%
- Beta
- 1.09
- R²
- 0.11
- Upside Capture
- 96.62%
- Downside Capture
- 139.97%
Return for Risk
Risk / Return Rank
JYNT ranks 14 for risk / return — above 14% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for The Joint Corp. (JYNT) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JYNT | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.10 | ||
| Sortino ratioReturn per unit of downside risk | -2.82 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.25 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | -0.79 | 2.00 | -2.80 |
| Martin ratioReturn relative to average drawdown | -1.24 | 8.49 | -9.73 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the The Joint Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the The Joint Corp. was 93.13%, occurring on Nov 9, 2023. The portfolio has not yet recovered.
The current The Joint Corp. drawdown is 92.27%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-93.13%Nov 2023 | 2y 2mo | — | 4y 11moSep 2021 - now | — |
-84.43%Jul 2016 | 1y 21d | 2y 8mo | 3y 8moJun 2015 - Mar 2019 | — |
-61.22%Mar 2020 | 7mo 27d | 7mo 23d | 1y 3moJul 2019 - Nov 2020 | COVID crash2020 |
-20.28%Jun 2019 | 17d | 1mo 8d | 1mo 25dMay 2019 - Jul 2019 | — |
-19.64%Mar 2015 | 13d | 1mo 2d | 1mo 15dMar 2015 - Apr 2015 | — |
Drawdown Indicators
| JYNT | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.13% | -56.78% | -36.35% |
Max Drawdown (1Y)Largest decline over 1 year | -31.46% | -9.10% | -22.36% |
Max Drawdown (3Y)Largest decline over 3 years | -56.57% | -18.90% | -37.67% |
Max Drawdown (5Y)Largest decline over 5 years | -93.13% | -25.43% | -67.70% |
Max Drawdown (10Y)Largest decline over 10 years | -93.13% | -33.92% | -59.21% |
Current DrawdownCurrent decline from peak | -92.27% | -1.58% | -90.69% |
Average DrawdownAverage peak-to-trough decline | -55.28% | -10.70% | -44.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.14% | 2.14% | +18.00% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of The Joint Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how The Joint Corp. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for JYNT, comparing it with other companies in the Medical Care Facilities industry. Currently, JYNT has a P/E ratio of 37.7. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for JYNT compared to other companies in the Medical Care Facilities industry. JYNT currently has a PEG ratio of 0.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for JYNT relative to other companies in the Medical Care Facilities industry. Currently, JYNT has a P/S ratio of 2.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for JYNT in comparison with other companies in the Medical Care Facilities industry. Currently, JYNT has a P/B value of 7.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with JYNT
Add The Joint Corp. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with JYNT